Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial

Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site-level update rather than a change to the study record content.
    Difference
    0.2%
    Check dated 2026-04-24T05:48:04.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be an internal update with no user-facing changes.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A UI/layout refresh was applied. Core study details such as eligibility criteria, primary/secondary outcomes, and participating sites appear unchanged.
    Difference
    0.1%
    Check dated 2026-04-09T20:59:18.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Screenshots show no detectable differences; the page content and layout appear unchanged. All listed sections and study details remain the same between images.
    Difference
    0.1%
    Check dated 2026-04-02T14:56:09.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    UI/layout refresh observed with no changes to core study data. Essential study sections such as eligibility, outcomes, and locations remain the same.
    Difference
    0.1%
    Check dated 2026-03-26T11:07:59.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Added the CLOVER-2 dose-escalation study title focusing on pediatric solid tumors, including Rhabdomyosarcoma, and updated the revision to v3.5.0. Replaced the previous broader CLOVER-2 description with the new title and scope.
    Difference
    0.5%
    Check dated 2026-03-19T00:15:05.000Z thumbnail image

Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.